{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:50:48Z","timestamp":1783612248619,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C3003334"],"award-info":[{"award-number":["NRF-2021R1A2C3003334"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jpain.2024.104552","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T12:43:20Z","timestamp":1714394600000},"page":"104552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0930-5997","authenticated-orcid":false,"given":"Young Gi","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yeoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehyun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-6895","authenticated-orcid":false,"given":"Seog Bae","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2024.104552_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jpain.2024.104552_bib2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2024.104552_bib3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22921","article-title":"Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature","volume":"110","author":"Badros","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2024.104552_bib4","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpain.2024.104552_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.2010.01533.x","article-title":"Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study","volume":"86","author":"Dimopoulos","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jpain.2024.104552_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hon.2706","article-title":"Characteristics and risk factors of bortezomib induced peripheral neuropathy: a systematic review of phase III trials","volume":"38","author":"Li","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jpain.2024.104552_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2017.88","article-title":"Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics","volume":"13","author":"Argyriou","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jpain.2024.104552_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65\/GMMG-HD4 trial","volume":"11","author":"Broyl","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpain.2024.104552_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11064-016-2007-9","article-title":"Genetic susceptibility to bortezomib-induced peripheral neuroropathy: replication of the reported candidate susceptibility loci","volume":"42","author":"Campo","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jpain.2024.104552_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hon.2391","article-title":"Bortezomib-induced peripheral neuropathy: a genome-wide association study on multiple myeloma patients","volume":"36","author":"Campo","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jpain.2024.104552_bib11","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3324\/haematol.2011.041434","article-title":"Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients","volume":"96","author":"Corthals","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jpain.2024.104552_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FPC.0b013e3283436b45","article-title":"Genetic variation associated with bortezomib-induced peripheral neuropathy","volume":"21","author":"Favis","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpain.2024.104552_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hon.2337","article-title":"Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array","volume":"35","author":"Garcia-Sanz","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jpain.2024.104552_bib14","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1158\/1078-0432.CCR-15-3163","article-title":"A genome-wide association study identifies a novel locus for bortezomib-induced peripheral neuropathy in European patients with multiple myeloma","volume":"22","author":"Magrangeas","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2024.104552_bib15","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1158\/1078-0432.CCR-15-0133","article-title":"Pharmacoethnicity in paclitaxel-induced sensory peripheral neuropathy","volume":"21","author":"Komatsu","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpain.2024.104552_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13073-014-0091-5","article-title":"Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations","volume":"6","author":"Li","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.jpain.2024.104552_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2024.104552_bib18","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpain.2024.104552_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12640-014-9514-8","article-title":"Toxic effects of bortezomib on primary sensory neurons and Schwann cells of adult mice","volume":"27","author":"Ale","year":"2015","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jpain.2024.104552_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918797042","article-title":"Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain","volume":"14","author":"Bechakra","year":"2018","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2024.104552_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","article-title":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","volume":"223","author":"Bruna","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2024.104552_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2024.104552_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ibra.12086","article-title":"Animal models of chemotherapy-induced peripheral neuropathy for hematological malignancies: a review","volume":"9","author":"Lv","year":"2022","journal-title":"Ibrain"},{"key":"10.1016\/j.jpain.2024.104552_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-018-1270-x","article-title":"High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats","volume":"15","author":"Meregalli","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jpain.2024.104552_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol Ther"},{"key":"10.1016\/j.jpain.2024.104552_bib26","article-title":"Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fumagalli","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jpain.2024.104552_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/ijms22020888","article-title":"Pathological mechanisms of bortezomib-induced peripheral neuropathy","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpain.2024.104552_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2567.2003.01738.x","article-title":"The MHC class I antigen presentation pathway: strategies for viral immune evasion","volume":"110","author":"Hewitt","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.jpain.2024.104552_bib29","doi-asserted-by":"crossref","first-page":"11772","DOI":"10.1074\/jbc.M707572200","article-title":"HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice","volume":"283","author":"Atkins","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2024.104552_bib30","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1091\/mbc.e07-03-0218","article-title":"HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2","volume":"18","author":"Lubben","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jpain.2024.104552_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/viro.2000.0816","article-title":"HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway","volume":"282","author":"Swann","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.jpain.2024.104552_bib32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood-2007-03-078535","article-title":"Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma","volume":"111","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2024.104552_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-021-02098-y","article-title":"Transcriptome profiling of long noncoding RNAs and mRNAs in spinal cord of a rat model of paclitaxel-induced peripheral neuropathy identifies potential mechanisms mediating neuroinflammation and pain","volume":"18","author":"Li","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jpain.2024.104552_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6319","article-title":"A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants","volume":"9","author":"Choi","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jpain.2024.104552_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz7835","article-title":"Korean Genome Project: 1094 Korean personal genomes with clinical information","volume":"6","author":"Jeon","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jpain.2024.104552_bib36","doi-asserted-by":"crossref","first-page":"baaa030","DOI":"10.1093\/database\/baaa030","article-title":"KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing","volume":"2020","author":"Jung","year":"2020","journal-title":"Database"},{"key":"10.1016\/j.jpain.2024.104552_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0968-0004(03)00052-5","article-title":"How introns influence and enhance eukaryotic gene expression","volume":"28","author":"Le Hir","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jpain.2024.104552_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1261\/rna.5250403","article-title":"A quantitative analysis of intron effects on mammalian gene expression","volume":"9","author":"Nott","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.jpain.2024.104552_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.tig.2019.09.010","article-title":"Introns: good day junk is bad day treasure","volume":"35","author":"Parenteau","year":"2019","journal-title":"Trends Genet"},{"key":"10.1016\/j.jpain.2024.104552_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrn3529","article-title":"Acid-sensing ion channels in pain and disease","volume":"14","author":"Wemmie","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpain.2024.104552_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neulet.2012.03.081","article-title":"Immunohistochemical localization of acid-sensing ion channel 2 (ASIC2) in cutaneous Meissner and Pacinian corpuscles of Macaca fascicularis","volume":"516","author":"Cabo","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2024.104552_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12929-018-0448-y","article-title":"Acid-sensing ion channels: dual function proteins for chemo-sensing and mechano-sensing","volume":"25","author":"Cheng","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jpain.2024.104552_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac256","article-title":"Distribution of acid-sensing ion channel subunits in human sensory neurons contrasts with that in rodents","volume":"4","author":"Papalampropoulou-Tsiridou","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.jpain.2024.104552_bib44","doi-asserted-by":"crossref","first-page":"43716","DOI":"10.1074\/jbc.M403557200","article-title":"Characterization of acid-sensing ion channels in dorsal horn neurons of rat spinal cord","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2024.104552_bib45","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.2132-21.2022","article-title":"Fibroblastic SMOC2 suppresses mechanical nociception by inhibiting coupled activation of primary sensory neurons","volume":"42","author":"Zhang","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2024.104552_bib46","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1073\/pnas.1912139117","article-title":"Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity","volume":"117","author":"Wolbert","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpain.2024.104552_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jpain.2024.104552_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101579","article-title":"The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN","volume":"298","author":"Nakano","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2024.104552_bib49","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1038\/s41598-019-45517-0","article-title":"In vivo measurements reveal a single 5\u2032-intron is sufficient to increase protein expression level in Caenorhabditis elegans","volume":"9","author":"Crane","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpain.2024.104552_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009100","article-title":"Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies","volume":"16","author":"Joynt","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jpain.2024.104552_bib51","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1152\/jn.01350.2007","article-title":"Biophysical properties of human Na v1.7 splice variants and their regulation by protein kinase A","volume":"99","author":"Chatelier","year":"2008","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jpain.2024.104552_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000218711","article-title":"Genetic variants associated with complex human diseases show wide variation across multiple populations","volume":"13","author":"Adeyemo","year":"2010","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.jpain.2024.104552_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2011.12.022","article-title":"Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci","volume":"90","author":"Saxena","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jpain.2024.104552_bib54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024004826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024004826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:01:54Z","timestamp":1756699314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590024004826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1526590024004826"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104552","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2024.104552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"104552"}}